文献速递产科母胎医学

孕中期母血清标志物与脑瘫风险

Second trimester maternal serum biomarkers and the risk of cerebral palsy.
PubMed 文献 · Prenat Diagn · 2021-07-21

本研究通过回顾性病例对照数据链接,将129例单胎脑瘫病例与每例10名对照(共1290名)的孕中期母血清筛查记录链接,比较AFP、β-hCG、uE3和抑制素水平。结果显示脑瘫妊娠的AFP和抑制素均值及异常升高比例均显著高于对照,两者同时升高时风险更高,且与早产和低出生体重相关。

要点

  • 脑瘫妊娠孕中期AFP和抑制素均值及异常升高比例均高于对照。
  • AFP和抑制素同时升高时脑瘫风险显著增加。
  • 高AFP和高抑制素水平与脑瘫病例中的早产和低出生体重相关。

核心结论

  • 孕中期AFP和抑制素异常升高与脑瘫风险增加相关,提示胎盘形成异常可能参与部分脑瘫病例的因果通路。

研究设计与样本

  • 回顾性病例对照数据链接研究,纳入129例单胎脑瘫病例和每例10名对照(共1290名),链接孕中期母血清筛查记录。

主要发现

  • 脑瘫妊娠AFP均值1.10 MoM vs 对照1.01 MoM(p=0.01)。
  • 脑瘫妊娠抑制素均值1.10 MoM vs 对照0.98 MoM(p≤0.01)。
  • AFP升高与脑瘫风险增加相关(OR 2.52 [95%CI 1.30, 4.65];p<0.01)。
  • 抑制素升高与脑瘫风险增加相关(OR 2.63 [95%CI 1.37, 4.77];p<0.01)。
  • AFP和抑制素同时升高时风险更高(OR 6.75 [95%CI 2.41, 18.94];p<0.01)。

临床怎么用

  • 孕中期发现AFP或抑制素异常升高时,可提示关注胎盘功能及后续脑瘫风险,但需结合其他临床信息综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To investigate whether second trimester maternal serum screening (2TMSS) biomarkers are associated with cerebral palsy (CP) and identify CP characteristics associated with abnormal biomarker levels. METHOD: In this retrospective case-control data linkage study, we linked mothers of 129 singleton CP cases from a population register to their 2TMSS records and selected 10 singleton pregnancy controls per case (n = 1290). We compared mean and abnormal levels of alpha-fetoprotein (AFP), beta subunit of human chorionic gonadotrophin (β-hCG), unconjugated estriol (uE3), and inhibin between cases and controls and within CP subgroups. RESULTS: Compared to control pregnancies, CP pregnancies had higher mean levels of AFP (1.10 vs. 1.01 multiple of the population median [MoM], p = 0.01) and inhibin (1.10 vs. 0.98 MoM, p ≤ 0.01). CP pregnancies were 2.5 times more likely to be associated with high levels of AFP (OR 2.52 [95% confidence interval [CI] 1.30, 4.65]; p < 0.01) and 2.6 times for inhibin (OR 2.63 [95% CI 1.37, 4.77]; p < 0.01), and 6.8 times when AFP and inhibin were both elevated (OR 6.75 [95% CI 2.41, 18.94]; p < 0.01). In CP cases, high AFP and high inhibin levels were associated with preterm birth and low birthweight. INTERPRETATION: Abnormal second-trimester biomarker levels suggest abnormal placentation plays a role in the causal pathway of some CP cases.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Peris M, Reid SM, Dobie S, et al. Second trimester maternal serum biomarkers and the risk of cerebral palsy. Prenat Diagn. 2021. PMID: 34270813. doi:10.1002/pd.6011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。